Imagion Biosystems Half-Year Results for the First Half of 2021 and Appendix 4D

1H2021 Highlights: Enrolment for the Phase I HER2 Breast Cancer Study commences Initiation of research for prostate cancer imaging supported by CSIRO funds…


Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer

Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement with Global Cancer Technology (GCT), to develop GCT’s novel…


Quarterly Activity Report and Appendix 4C for 30 June 2021

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 30 June 2021. The report highlights that during the quarter the…


Presentation Visuals from 28th May 2021 Annual General Meeting

The presentation visuals from the 28th May 2021 Annual General Meeting are now available. Download here.


Imagion Biosystems Receives A$2.6 Million R&D Tax Incentive

Imagion Biosystems Limited is pleased to announce that it has received its 2020 R&D tax incentive claim of $2,612,159 from the Australian Taxation…


First Patient Enrolled in Phase I MagSense® HER2+ Breast Cancer Study

This week Imagion Biosystems has announced we have enrolled our first patient into our first clinical study. This is an important step for our Phase I…


Imagion Biosystems and Patrys Limited to Collaborate on Brain Tumor Imaging

Imagion Biosystems is pleased to announce a partnership with the ASX-listed therapeutic antibody development company Patrys Limited. The collaborative research…


Quarterly Activity Report — Period ending 31 March 2021

Imagion Biosystems is pleased to report that we closed the first quarter of FY2021 maintaining a strong cash balance and having added a new study site for our…


Imagion Biosystems March 2021 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its March 2021 Investor Newsletter. The newsletter details recent new company developments and…


Imagion Receives CSIRO Federal Government Grant for Prostate Cancer Project

Imagion Biosystems is pleased to announce it is a proud recipient of an Innovations Connections grant from the Australian Government’s Department of Industry,…